JUVAF

Juva Life Inc.
OTC Markets OTCPKUSDEQUITY Healthcare DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
100
Market cap
$1.64K
P/E (TTM)
—
52W range
0.00 – 0.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
0.00% -1.6%
1M
0.00% -1.1%
3M
0.00% -3.0%
6M
0.00% -14.6%
YTD
0.00% -13.6%
1Y
0.00% -15.3%
3Y
-99.97% -181.2%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on JUVAF open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
50.58M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Sep 6, 22
Ruditsky (Neil)
Senior Officer of Issuer
BUY 71.00K $9.73K Direct
Aug 17, 22
Ruditsky (Neil)
Senior Officer of Issuer
BUY 29.00K $3.94K Direct
Feb 10, 22
Ruditsky (Neil)
Senior Officer of Issuer
BUY 48.00K $9.79K Direct
Feb 7, 22
Ruditsky (Neil)
Senior Officer of Issuer
BUY 42.00K $8.95K Direct
Feb 7, 22
Ruditsky (Neil)
Senior Officer of Issuer
BUY 20.00K $4.10K Direct
Jan 20, 22
Ruditsky (Neil)
Senior Officer of Issuer
BUY 20.00K $4.48K Direct
Jan 19, 22
Ruditsky (Neil)
Senior Officer of Issuer
BUY 20.00K $4.40K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

1 reporting
NameRelationShares heldLatest
Ruditsky (Neil)
Senior Officer of Issuer 1.11M Acquisition or disposition in the public market

Fundamentals

TTM · reported
Market cap$1.64K
Enterprise value$9.56M
Revenue (TTM)$7.93M
Gross profit$1.40M
EBITDA$-4.29M
Net income$-6.81M
EPS (TTM)$-0.00
Free cash flow$-2.27M
Total cash$952.37K
Total debt$10.51M
Book value / share$0.03
Shares outstanding164.07M
Float125.21M
Short % of float—
Dividend yield0.00%
Beta (5Y)-8.96

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.00
EV / revenue1.21
EV / EBITDA-2.23
Gross margin17.69%
Operating margin-23.50%
Profit margin-85.89%
Return on equity-105.68%
Return on assets-14.44%
Debt / equity222.28
Current ratio0.70
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter — — $0 —
Next quarter — — $0 —
Current year — — $0 —
Next year — — $0 —

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders30.83%
Held by institutions0.00%
Institutions holding0
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.00
-100.00% from price
SMA 20
0.00
0.00% from price
SMA 50
0.00
0.00% from price
SMA 100
0.00
-100.00% from price
SMA 200
0.00
0.00% from price
EMA 12
0.00
-100.00% from price
EMA 26
0.00
-100.00% from price
EMA 50
0.00
-100.00% from price
RSI (14)
7.2
Oversold
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
—
Realised vol 30D
0.0%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
0.00%

Options chain

Account required
Expiry
Spot 0.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
—
—
Realised vol 30D
0.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
0.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
-8.96
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.